Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.Geurs named new School of Dentistry dean
Nicolaas Geurs, D.D.S., M.S., inaugural holder of UAB's Weatherford-Palcanis Endowed Professorship in Dentistry and the Dental Alumni-Joseph F. Volker Chair of Clinical Dentistry, has been selected as the next dean of the UAB School of Dentistry following a national search. He will begin his new role June 1.
Updates on FLSA changes coming soon
UAB Police holds promotion ceremony
Healthy Women Needed for a Research Study
Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email: urogynecology@uabmc.edu
A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)
TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.
- Are aged 18 years or older
- Have type 2 diabetes
- Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
- Have a BMI of 25 or more
- Have HbA1c levels of 7.0% to 10.5%
To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu